Is Less More? Does Decreasing OnabotulinumtoxinA Injection Sites in the Bladder Increase Patient Satisfaction While Maintaining Efficacy?
Phase of Trial: Phase IV
Latest Information Update: 25 Sep 2018
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- 14 Sep 2018 Status changed from not yet recruiting to recruiting.
- 09 Jul 2018 Planned initiation date changed from 1 Jun 2018 to 1 Aug 2018.
- 17 May 2018 New trial record